|
Re: Aug 29 Article Abstract - European Heart Journal (Case Reports?)
|
1
|
Resverlogix Corp.
|
Sep 26, 2017 09:41AM
|
|
Article. Apabetalone apparently mentioned
|
1
|
Resverlogix Corp.
|
Oct 07, 2021 05:11AM
|
|
Re: orphan diseases
|
1
|
Resverlogix Corp.
|
Jul 04, 2018 12:35AM
|
|
Re: BET inhibition and epilepsy
|
1
|
Resverlogix Corp.
|
Jun 09, 2021 05:53AM
|
|
Re: Rough Transcript - RVX Confernce Call - 02/04/2021
|
1
|
Resverlogix Corp.
|
Feb 13, 2021 06:00PM
|
|
Re: Patience
|
1
|
Resverlogix Corp.
|
Jun 22, 2021 01:37PM
|
|
Re: Patience
|
1
|
Resverlogix Corp.
|
Jun 22, 2021 01:46PM
|
|
Zenith Epigenetics 1407__ Epicongress Boston July 2014
|
1
|
Resverlogix Corp.
|
May 20, 2015 02:15PM
|
|
Re: COVID-19 "competition" to keep an eye on.
|
1
|
Resverlogix Corp.
|
Feb 12, 2021 06:56AM
|
|
Re: Drug Discovery Targeting BRD4
|
1
|
Resverlogix Corp.
|
Oct 05, 2017 09:11PM
|
|
Re: Summary of Proposed BETonMACE2 design and timelines
|
1
|
Resverlogix Corp.
|
Feb 12, 2021 07:07AM
|
|
60/160 Treatments in Development for CoronaVirus - Did not see Apabetalone in Quick Scan
|
1
|
Resverlogix Corp.
|
Apr 25, 2020 12:05AM
|
|
Re: Where is the trial?
|
1
|
Resverlogix Corp.
|
Apr 24, 2021 03:54PM
|
|
Re: Covid and BETonMACE, etc. Rambling.
|
1
|
Resverlogix Corp.
|
Apr 24, 2021 04:00PM
|
|
Re: A little social experiment with Google Trends....
|
1
|
Resverlogix Corp.
|
Oct 31, 2017 04:07PM
|
|
Zenith Meeting audio?
|
1
|
Zenith Epigenetics
|
Nov 13, 2019 04:14AM
|
|
Re: Also interesting, but less encouraging
|
1
|
Resverlogix Corp.
|
Aug 04, 2022 05:06PM
|
|
Re: Tablet vs Capsule
|
1
|
Resverlogix Corp.
|
Feb 22, 2021 03:00AM
|
|
Re: Not good for the potential of apabetalone as a Covid-19 therapy
|
1
|
Resverlogix Corp.
|
Dec 03, 2021 05:26AM
|
|
Re: Veterinary Applications?
|
1
|
Zenith Epigenetics
|
Aug 09, 2017 05:32AM
|
